Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CO free. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover a scalable, eco-friendly synthesis route for KRAS inhibitor intermediate with 33% yield. Reduce costs and supply chain risks for your API production.
Solve supply chain risks with this glucose-based 1,2,4-triazole synthesis. No anhydrous conditions, high yield, scalable to 100MT. Contact for custom synthesis.
Eliminate CO gas risks and high costs in biheterocyclic synthesis. Our CDMO expertise scales this patent method to 100MT/yr with >99% purity for drug development.
Eliminate anhydrous/oxygen-free requirements in 1,2,4-triazole synthesis. Scale to gram-level with biomass-derived glucose. Reduce production costs by 30% for drug development.
Discover cost-effective cobalt-catalyzed synthesis of tetrahydro-β-carbolinone for anti-anxiety drugs. High yield, broad functional group tolerance, and scalable to 100 MT/yr. Reduce supply chain risks.
Discover a metal-free, high-yield method for chiral 1,3-diamine with >97:3 dr. Reduce costs and supply chain risks in pharmaceutical synthesis.
Discover how CO-free palladium-catalyzed synthesis of 2-trifluoromethyl quinazolinones reduces safety risks and costs for pharmaceutical intermediates. Scale-ready solution for R&D and procurement teams.
Discover a scalable, metal-free synthesis for trifluoromethyl dihydrofuranamine with >99% purity. Reduce supply chain risks and accelerate drug development with our CDMO expertise.
Discover cost-effective, high-yield synthesis of trifluoromethyl benzo[1,8]naphthyridine for OLEDs. Reduce raw material costs by 30-40% with scalable CDMO solutions.
Solve isoquinolinone synthesis challenges with 92%+ yields, oxygen-based oxidation, and 5-step routes. Reduce costs and supply risks for pharma intermediates.
Discover a novel glucose-based synthesis for 3-trifluoromethyl-1,2,4-triazole compounds. Eliminate anhydrous conditions, reduce costs, and ensure supply chain stability for your pharmaceutical intermediates.
Solve supply chain risks with metal-free carbonylation. Low-cost, scalable synthesis of trifluoromethylated biheterocycles for pharma R&D and production.
Discover how cobalt-catalyzed C-H activation enables cost-effective 1H-indole-2-amide production for MAO-A inhibitors and NMDA antagonists. Reduce supply chain risks with scalable chemistry.
Solve toxic CO gas risks in biheterocyclic synthesis. Our CDMO expertise enables scalable, high-purity production for drug development. Contact for COA/MSDS.
Discover a 98% yield, low-waste synthesis of tetrafluoroterephthalate for pyrethroid insecticides. Eliminate strong acid corrosion and high energy costs in your supply chain.
Eliminate palladium catalysts and anhydrous conditions in vismodegib production. Achieve 99% purity with 50% yield using copper-catalyzed route. Reduce costs by 30%.
Solve low enantioselectivity & high catalyst cost in alpha-hydroxy-beta-keto ester production. 97% ee, 95% yield, 5-25 mol% catalyst. Scale to 100 MT/yr with NINGBO INNO PHARMCHEM.
Solve CO handling risks in quinazolinone synthesis. Our CDMO expertise delivers high-yield, scalable 2-CF3-quinazolinone production with 99% purity for drug development.
Eliminate catalyst costs and harsh conditions in quinoline synthesis. Our CDMO expertise scales this 90%+ yield process for stable API supply chains.
Eliminate CO gas risks and high costs in biheterocyclic synthesis. Our CDMO expertise scales this CO-free palladium method for high-purity pharmaceutical intermediates with >99% purity.